Kristiina Iljin

- Docent,
Institute of Biomedicine (Faculty of Medicine)

heiilj@utu.fi

Itäinen Pitkäkatu 4

Turku

High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer (2016)
- Journal of Molecular Biochemistry
Kirsi Ketola, Miro Viitala, Pekka Kohonen, Vidal Fey, Zoran Culig, Olli Kallioniemi, Kristiina Iljin
REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker (2016)
- PLoS ONE
Laura Lehtinen, Pia Vesterkvist, Pia Roering, Taina Korpela, Liisa Hattara, Katja Kaipio, John-Patrick Mpindi, Johanna Hynninen, Annika Auranen, Ben Davidson, Caj Haglund, Kristiina Iljin, Seija Grenman, Harri Siitari, Olli Carpen
Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions (2015)
- International Journal of Cancer
Saeed K, Ostling P, Bjorkman M, Mirtti T, Alanen K, Vesterinen T, Sankila A, Lundin J, Lundin M, Rannikko A, Nordling S, Mpindi JP, Kohonen P, Iljin K, Kallioniemi O, Rantala JK
Characterization of Leukocyte Formin FMNL1 Expression in Human Tissues (2014)
- Journal of Histochemistry and Cytochemistry
Gardberg M, Heuser VD, Iljin K, Kampf C, Uhlen M, Carpen O
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients (2014)
- Oncotarget
Harriet Wikman, Laura Westphal, Felicitas Schmid, Sirkku Pollari, Jolanthe Kropidlowski, Bettina Sielaff-Frimpong, Markus Glatzel, Jakob Matschke, Manfred Westphal, Kristiina Iljin, Heini Huhtala, Luigi Terracciano, Anne Kallioniemi, Guido Sauter, Volkmar Müller, Isabell Witzel, Katrin Lamszus, Dirk Kemming, Klaus Pantel
FHOD1, a Formin Upregulated in Epithelial-Mesenchymal Transition, Participates in Cancer Cell Migration and Invasion (2013)
- PLoS ONE
Gardberg M, Kaipio K, Lehtinen L, Mikkonen P, Heuser VD, Talvinen K, Iljin K, Kampf C, Uhlen M, Grenman R, Koivisto M, Carpen O
High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion (2013)
- Oncotarget
Lehtinen L, Ketola K, Makela R, Mpindi J, Viitala M, Kallioniemi O, Iljin K
Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergistic Agent with Disulfiram in Prostate Cancer Cells (2012)
- PLoS ONE
Ketola K, KALLIONIEMI O, Iljin K
c-Jun N-Terminal Kinase Phosphorylation of MARCKSL1 Determines Actin Stability and Migration in Neurons and in Cancer Cells (2012)
- Molecular and Cellular Biology
Bjorkblom B, Padzik A, Mohammad H, Westerlund N, Komulainen E, Hollos P, Parviainen L, Papageorgiou AC, Iljin K, Kallioniemi O, Kallajoki M, Courtney MJ, Magard M, James P, Coffey ET
High-throughout transriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer (2012)
- PLoS ONE
Paula Vainio, John-Patrick Mpindi, Pekka Korhonen, Vidal Fey, Tuomas Mirtti, Kalle A Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin
Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer (2012)
- Prostate
Vainio Paula, Wolf Maija, Edgren Henrik, He Tao, Kohonen Pekka, Mpindi John-Patrick, Smit Frank, Verhaegh Gerald, Schalken Jack, Perälä Merja, Iljin Kristiina, Kallioniemi Olli
Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling (2012)
- Journal of Biological Chemistry
Paatero I, Jokilammi A, Heikkinen PT, Iljin K, Kallioniemi OP, Jones FE, Jaakkola PM, Elenius K
Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress (2012)
- British Journal of Cancer
Ketola K, Hilvo M, Hyotylainen T, VUORISTO A, Ruskeepaa AL, ORESIC M, KALLIONIEMI O, Iljin K
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer (2011)
- American Journal of Pathology
Vainio Paula, Gupta Santosh, Ketola Kirsi, Mirtti Tuomas, Mpindi John-Patrik, Kohonen Pekka, Fey Vidal, Perälä Merja, Smit Frank, Verhaegh Gerald, Schalken Jack, Alanen Kalle A, Kallioniemi Olli, Iljin Kristiina
Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins (2011)
- Oncotarget
Vainio Paula, Lehtinen Laura, Mirtti Tuomas, Hilvo Mika, Seppänen-Laakso Tuulikki, Virtanen Johannes, Sankila Anna, Nordling Stig, Lundin Johan, Rannikko Antti, Orešic Matej, Kallioniemi Olli, Iljin Kristiina
Characterization of Diaphanous-related formin FMNL2 in human tissues. (2010)
- BMC Cell Biology
Gardberg M, Kaipio K, Talvinen K, Iljin K, Kampf C, Uhlen M, Carpén O
FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells (2010)
- Cancer Research
Gupta S, Iljin K, Sara H, Mpindi JP, Mirtti T, Vainio P, Rantala J, Alanen K, Nees M, Kallioniemi O
Integrative Functional Genomics Analysis of Sustained Polyploidy Phenotypes in Breast Cancer Cells Identifies an Oncogenic Profile for GINS2 (2010)
- Neoplasia
Rantala JK, Edgren H, Lehtinen L, Wolf M, Kleivi K, Vollan HKM, Aaltola AR, Laasola P, Kilpinen S, Saviranta P, Iljin K, Kallioniemi O
Monensin Is a Potent Inducer of Oxidative Stress and Inhibitor of Androgen Signaling Leading to Apoptosis in Prostate Cancer Cells (2010)
- Molecular Cancer Therapeutics
Ketola K, VAINIO P, FEY V, KALLIONIEMI O, Iljin K